English | Español
Patient Daily | Apr 10, 2026

Biopharma R&D professionals advised to focus on skills in AI-driven economy
Patient Daily | Apr 10, 2026

IO Biotech files for bankruptcy and plans to liquidate assets after FDA setback
Patient Daily | Apr 10, 2026

FDA links Amgen's Tavneos to eight deaths and liver injuries in safety alert
Patient Daily | Apr 10, 2026

Experts discuss advances and challenges in radiotherapeutics for cancer treatment
Patient Daily | Apr 10, 2026

Biopharma companies announce major acquisitions and rare disease drug approvals
Patient Daily | Apr 10, 2026

Eleven startups join Drive accelerator program for life sciences innovation
Patient Daily | Apr 10, 2026

Biotech IPOs rebound as AI becomes central in drug development
Patient Daily | Apr 10, 2026

Ambrosia Biosciences raises $100 million to develop small-molecule GLP-1 obesity drugs

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science